1
Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy Subjects
Condition(s):InfluenzaLast Updated:September 22, 2022Completed
Hide Studies Not Open or Pending
Condition(s):InfluenzaLast Updated:September 22, 2022Completed
Condition(s):Myasthenia Gravis, GeneralizedLast Updated:May 30, 2018Withdrawn
Condition(s):Myasthenia GravisLast Updated:January 28, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.